HITLAB Releases Evidence Report on MedsEngine®, Validating Nation-Leading Chronic Disease Control Outcomes in Primary Care
New Collaboration Will Support Platform Evaluation, Evidence Synthesis, and Strategic Communications to Help Strengthen VitalFriend’s Innovation Roadmap
HITLAB and ENB Therapeutics Partner to Transform Immunotherapy-Resistant Cancers into Clinical Victories